Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/ β-Catenin and PI3K/AKT Signaling Pathways

Cell Mol Neurobiol. 2023 Sep 25. doi: 10.1007/s10571-023-01414-9. Online ahead of print.ABSTRACTGliomas are a deadly primary malignant tumor of the central nervous system, with glioblastoma (GBM) representing the most aggressive type. The clinical prognosis of GBM patients remains bleak despite the availability of multiple options for therapy, which has needed us to explore new therapeutic methods to face the rapid progression, short survival, and therapy resistance of glioblastomas. As the Human Genome Project advances, long noncoding RNAs (lncRNAs) have attracted the attention of researchers and clinicians in cancer research. Numerous studies have found aberrant expression of signaling pathways in glioma cells. For example, lncRNAs not only play an integral role in the drug resistance process by regulating the Wnt/β-catenin or PI3K/Akt signaling but are also involved in a variety of malignant biological behaviors such as glioma proliferation, migration, invasion, and tumor apoptosis. Therefore, the present review systematically assesses the existing research evidence on the malignant progression and drug resistance of glioma, focusing on the critical role and potential function of lncRNAs in the Wnt/β-catenin and PI3K/Akt classical pathways to promote and encourage further research in this field.PMID:37747595 | DOI:10.1007/s10571-023-01414-9
Source: Cellular and Molecular Neurobiology - Category: Cytology Authors: Source Type: research